2026 Endocrine Case Management: Meet the Professor

Availability

On-Demand

Release on Jun 13, 2026 8:00 AM Central Daylight Time
Expires on Dec 31, 2028

Cost

Member: $89.00

Non-Member: $109.00

In-Training Member: $69.00

Resident Member: $89.00

Resident Non-Member: $109.00

Credit Offered

30 AMA PRA Category 1 Credits

30 ABIM-MOC Points

30 Participation Credits

Course Description
Target Audience
Learning Objectives
Accreditation Statement
Faculty and Disclosures

Endocrine Case Management: Meet the Professor is designed to provide physicians with a concise and high-quality review of more than 40 common and rare endocrine disorders to help you keep your practice current. It consists of case-based clinical vignettes and rationales by experts in all areas of endocrinology, diabetes, and metabolism.

Endocrine Case Management: Meet the Professor provides case-based education to clinicians interested in improving patient care.

Endocrine Case Management: Meet the Professor will allow learners to assess their knowledge of all aspects of endocrinology, diabetes, and metabolism.

Upon completion of this educational activity, learners will be able to:

Recognize clinical manifestations of endocrine and metabolic disorders and select among current options for diagnosis, management, and therapy.
Identify risk factors for endocrine and metabolic disorders and develop strategies for prevention.
Evaluate endocrine and metabolic manifestations of systemic disorders.
Use existing resources pertaining to clinical guidelines and treatment recommendations for endocrine and related metabolic disorders to guide diagnosis and treatment.

AMA PRA Category 1 Credit
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has received Accreditation with Commendation.

The Endocrine Society designates this enduring material for a maximum of 30 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 30 Maintenance of Certification (MOC) points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to Accreditation Council for Continuing Medical Education (ACCME) for the purpose of granting ABIM MOC credit. At the time of submission, please ensure your full name, Diplomate ID and birthdate match ABIM’s records or MOC points may be rejected by ABIM.

CME credits and/or MOC points for the activities related to this material must be claimed by December 31, 2028. For questions about content or obtaining CME credit or MOC points, please contact the Endocrine Society at info@endocrine.org.

2026 Endocrine Case Management: Meet the Professor Faculty

José O. Alemán-Diaz, MD, PhD

AdventHealth Orlando

Dalal S. Ali, MD, MSc

McMaster University

Richard J. Auchus, MD, PhD

University of Michigan

Irina Bancos, MD, MSc

Mayo Clinic

Rodica Busui, MD, PhD

Oregon Health and Science University

Maria E. Cabanillas, MD

The University of Texas MD Anderson Cancer Center

Angela M. Cheung, MD, PhD, CCD

University of Toronto

Miguel Debono, MD, PhD

University of Sheffield

Martin den Heijer, MD, PhD

Amsterdam UMC

Guido Di Dalmazi, MD

University of Bologna

Sorahia Domenice, MD

University of São Paulo

Juliana Beaudette Drummond, MD, PhD

Federal University of Minas Gerais

Aoife Maria Egan, MB BCh, BAO, PhD

Mayo Clinic

Alexander T. Faje, MD

Massachusetts General Hospital

Erin Finn, MD

University of Colorado Anschutz

W. Timothy Garvey, MD

University of Alabama at Birmingham

Christian Girgis, MBBS, PhD

Westmead Hospital and The University of Sydney

Jerry R. Greenfield, MD, PhD

Victor Change Cardiac Research Institute, St. Vincent’s Hospital, and University of New South Wales

Peyman Hadji, MD

Frankfurt am Main and Philipps-University of Marburg

Thorvardur (Thor) R. Halfdanarson, MD

Mayo Clinic

Niki Karavitaki, MBChB, MSc, PhD

University of Birmingham and Queen Elizabeth Hospital

Aliya A. Khan, MD

McMaster University

Sun Y. Lee, MD, MSc

Boston University Chobanian and Avedisian School of Medicine

David Suphadetch Leungsuwan, MBBS, MMed

Changi General Hospital

George Mastorakos, MD, DmedSc, MSc

National and Kapodistrian University of Athens

Michael T. McDermott, MD

University of Colorado School of Medicine

Berenice B. Mendonca, MD

University of São Paulo

Jennifer L. Miller, MD, MS

University of Florida

Oscar L. Morey-Vargas, MD

Cleveland Clinic

Kalpana Muthusamy, MBBS, MD

Mayo Clinic

Lisa Nachtigall, MD

Mass General Brigham and Harvard Medical School

John Newell-Price, MD, PhD

University of Sheffield

Anna Nordenström, MD, PhD

Karolinska Institute and Karolinska University Hospital

Georgia Ntali, MBChB, MSc, PhD

Evangelismos Hospital, University of Birmingham, and Queen Elizabeth Hospital

Juan Carl Pallais, MD, MPH

Brigham and Women's Hospital, Mass General Brigham, and Harvard Medical School

Christina Pamporaki, MD, PhD

University Hospital Carl Gustav Carus TU Dresden

Robin Peeters, MD, PhD

Erasmus Medical Center, Rotterdam

Troy H. Puar, MBBS, PhD

Changi General Hospital

Richard J. M. Ross, MBBS, MD

University of Sheffield

Mabel Ryder, MD

Mayo Clinic

Pankaj Shah, MD

Mayo Clinic

Omair A. Shariq, MBBS, PhD

Mayo Clinic

Vinaya Simha, MD

Mayo Clinic

Beatriz Santana Soares, MD, PhD

Federal University of Minas Gerais

Harilena Tsourouktsoglou, MD

National and Kapodistrian University of Athens

Anand Vaidya, MD, MMSc

Mass General Brigham and Harvard Medical School

Georgios Valsamakis, MD, PhD

National and Kapodistrian University of Athens

Benjamin Wilson, BA

Boston University

Lori J. Wirth, MD

Mass General Brigham Cancer Institute and Harvard Medical School

Kevin C. J. Yuen, MD

University of Arizona College of Medicine and Creighton School of Medicine

Annual Meeting Steering Committee (AMSC)

Barbara Gisella Carranza Leon, MD – AMSC Chair

Vanderbilt University Medical Center

Ana Paula Abreu Metzger, MD, PhD – Clinical Practice Chair

Brigham and Women's Hospital

Raghavendra Mirmira, PhD, MD – Clinical Science Chair

University of Chicago

Erik Nelson, BSc, PhD – Basic Science Chair

University of Illinois at Urbana-Champaign

Annual Meeting Steering Committee Clinical Peer Reviewers

Olga Astapova, MD, PhD; Laura Boucai, MD; Ana Pinheiro Machado Canton, MD, PhD; Diane Donegan, MBBCh BAO, MRCPI; Christa E. Flueck, MD; Oksana Hamidi, DO; Edward Chiaming Hsiao, MD, PhD; Hebatullah M. Ismail, MD; Suzanne Jan De Beur, MD; Peter Kamenicky, MD, PhD; Srividya Kidambi, MD; Katja Kiseljak-Vassiliades, DO; Connie Baum Newman, MD; Theodora Pappa, MD, PhD; Elizabeth N. Pearce, MD, MSc; Luca Persani, MD, PhD; Julie Refardt, MD, PhD; Laura Torchen, MD; Elena Tsourdi, MD; Adina Turcu, MD, MS; Jun Yang, MBBS, PhD; and Corrine Welt, MD.

[AY1]This peer review is not listed anywhere in the disclosures

STATEMENT OF INDEPENDENCE

As a CME provider accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy to ensure that the content of this educational activity is high-quality, balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s Annual Meeting Steering Committee.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in a position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined as remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that enables them to make their own judgments about whether these financial relationships may have influenced the educational activity’s exposition or conclusions. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The Endocrine Society has reviewed these relationships to determine which are relevant to this activity's content and has resolved any identified conflicts of interest for these individuals.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Richard J. Auchus, MD, PhD Adrenas (Contracted Research), Aspect Biosystems (Consultant), Crinetics (Consultant and Contracted Research), Lundbeck (Consultant), Lundbeck (Contracted Research), Merck (Consultant), Neurocrine (Consultant and Contracted Research), OMass (Consultant), Vertex (Consultant).

Rodica Busui, MD, PhD Novo Nordisk (Clinical Trial Investigator and Consultant), Averitas Pharma (Consultant), Bayer Inc. (Clinical Trial Investigator and Consultant), Lexicon (Clinical Trial Investigator and Consultant), Roche Diagnostics (Consultant), and Vertex (Consultant).

Maria E. Cabanillas, MD Bayer Inc. (Consultant), EISAI (Research funding), Exelixis (Consultant and Research Funding), Genentech (Research Funding), Lilly (Consultant), Merck (Research Funding), and Novartis (Consultant).

W. Timothy Garvey, MD Novo Nordisk (Advisory Board and Clinical Trial Investigator), AbbVie (Advisory Board), Boehringer-Ingelheim (Advisory Board), Corcept Therapeutics (Advisory Board), Eli Lilly & Company (Advisory Board and Clinical Trial Investigator), Fractyl Health (Advisory Board), Gan & Lee (Advisory Board), Graviton Biosciences (Advisory Board), i2o Therapeutics (Advisory Board), Kaleira (Clinical Trial Investigator), Keros Therapeutics (Advisory Board), Madrigal (Advisory Board), Neurocrine Biosciences (Advisory Board), Pfizer (Advisory Board), Regeneron, (Advisory Board), Roche Pharmaceuticals (Advisory Board and Clinical Trial Investigator), TERNS Pharmaceuticals (Advisory Board and Clinical Trial Investigator), Viking Therapeutics (Clinical Trial Investigator), and Zealand (Advisory Board and Clinical Trial Investigator).

Christian Girgis, MBBS, PhD Theramex (Advisory Board).

Jerry R. Greenfield, MBBS, PhD Novo Nordisk (Recipient of drug and placebo for a study of semaglutide in type 1 diabetes).

Thorvardur R. Halfdanarson, MD Biomea Fusion (Advisory Board), Boehringer Ingelheim (Advisory Board), Camurus (Clinical Trial Investigator), Crinetics (Clinical Trial Investigator), Curium (Advisory Board), Exelixis (Advisory Board and Clinical Trial Investigator), ITM (Clinical Trial Investigator), Novartis (Clinical Trial Investigator), Perspective Therapeutics (Clinical Trial Investigator), RayzeBio (Clinical Trial Investigator), Rezolute (Clinical Trial Investigator), Sanofi (Advisory Board), and Thermo Fisher (Clinical Trial Investigator).

Aliya A. Khan, MD Ascendis Pharma (Grant Recipient).

Sun Y. Lee, MD, MSc Alcimed (Consultant), American Association of Clinical Endocrinology (Honorarium Recipient), Florida Endocrinology Association (Honorarium Recipient), and Gudiepoint (Consultant).

Jennifer L. Miller, MD, MS Rhythm Therapeutics (Clinical Trial Investigator) and Soleno Therapeutics (Clinical Trial Investigator).

Oscar L. Morey-Vargas, MD Asofarma (Teaching and Speaking).

Lisa Nachtigall, MD Camurus (Advisory Board), Chiesi (Advisory Board, Consultant, and Contracted Research), Crinetics (Advisory Board and Consultant), and Recordati Rare Disease (Advisory Board and Grant Recipient).

John Newell-Price, MD, PhD Crinetics (Advisory Board), Recordati (Writing Committee), and Sparrow Therapeutics (Grant Recipient).

Juan Carl Pallais, MD, MPH Alesta Therapeutics (Consultant), Alexion Pharmaceuticals Inc. (Grant Recipient), Alexion Pharmaceuticals Inc. (Honorarium Recipient), Ensho Health (Advisory Board), Soft Bones (Speakers' Bureau), UpToDate (Author).

Troy H. Puar, MBBS, PhD AstraZeneca (Clinical Trial and Travel Grant).

Richard J. M. Ross, MBBS, MD Neurocrine (Consultant).

Anand Vaidya, MD, MMSc AstraZeneca (Consultant), Corcept (Consultant), Doris Duke Charitable Foundation (Grant Recipient), Mineralys (Advisory Board), and NIH (Grant Recipient).

Benjamin Wilson, BA Neurocrine Biosciences (Consultant).

Lori J. Wirth, MD AbbVie Inc (Advisory Board), Bicara (Advisory Board), Coherus (Advisory Board), EISAI (Consultant), Fore Biopharma (Advisory Board), Leo Pharma (Advisory Board), Novartis (Consultant), Pyxis (Advisory Board), and Tubulis (Advisory Board).

Kevin C. J. Yuen, MD Ascendis Pharma (Advisory Board and Contracted Research), Camurus (Advisory Board), Chiesi (Advisory Board), Crinetics (Advisory Board), Neurocrine (Advisory Board and Speakers' Bureau), Novo Nordisk (Advisory Board, Contracted Research, and Speakers' Bureau), Recordati (Advisory Board and Speakers' Bureau), and Sparrow Therapeutics (Contracted Research).

The following faculty reported no relevant financial relationships:

José O. Alemán-Diaz, MD, PhD; Dalal S. Ali, MD, MSc; Irina Bancos, MD, MSc; Angela M. Cheung, MD, PhD, CCD; Miguel Debono, MD, PhD; Martin den Heijer, MD, PhD; Guido Di Dalmazi, MD; Sorahia Domenice, MD; Juliana Beaudette Drummond, MD, PhD; Aoife Maria Egan, MB BCh, BAO, PhD; Alexander T. Faje, MD; Erin Finn, MD; Peyman Hadji, MD; Niki Karavitaki, MBChB, MSc, PhD; David Suphadetch Leungsuwan, MBBS, MMed; George Mastorakos, MD, DmedSc, MSc; Michael T. McDermott, MD; Berenice B. Mendonca, MD; Kalpana Muthusamy, MBBS, MD; Anna Nordenström, MD, PhD; Georgia Ntali, MBChB, MSc, PhD; Christina Pamporaki, MD, PhD; Robin Peeters, MD, PhD; Mabel Ryder, MD; Pankaj Shah, MD; Omair A. Shariq, MBBS, PhD; Vinaya Simha, MD; Beatriz Sanatana Soares, MD, PhD; Harilena Tsourouktsoglou, MD; and Georgios Valsamakis, MD, PhD.

The following AMSC peer reviewers reported relevant financial relationships:

Barbara Gisella Carranza Leon, MD Novartis, IONIS Pharmaceutical Inc, NIH, FH Foundation, Regenxbio, Inc (Coinvestigator), Maintenance of Certification Committee: American Board of Obesity Medicine (Member).

Diane Donegan, MB BCh BAO, MRCPI Corcept, Recordati (Investigator); Camarus (Advisory Board).

Christa E. Flueck, MD European Society Paediatric Endocrinology (Advisory Board); Novo Nordisk, Merck, Pfizer, Sandoz, Swiss National Science Foundation, European Society Paediatric Endocrinology (Grant Recipient); Novo Nordisk, Pfizer, EffRx (Consultant); Sandoz (Speaker); Hormone Research Paediatrics (Editor).

Oksana Hamidi, DO Corcept Therapeutics, Crinetics Pharmaceuticals, Neurocrine Biosciences, Recordati Rare Diseases, Camurus (Advisory Board); Xeris Pharma (Speaker).

Edward Chiaming Hsiao, MD, PhD International FOP Association, FD/MAS Alliance, International Clinical Council on FOP (Advisory Board); Endocrine Journal, Journal of Bone and Mineral Research (Editor); Clementia Pharmaceuticals/Ipsen Pharmaceuticals, Ultragenyx (Research Investigator).

Suzanne Jan De Beur, MD American Society of Bone and Mineral Research (Past President); XLH Network, Current Osteoporosis Reports, Ultragenyx, Kyowa Kirin, Ascendis (Advisory Board); Bone Reports (Editorial Board); Mereo, Kyowa Kirin, Calcilytics (Researcher); NIH, FDA (Grant Reviewer); PCORI (Investigator).

Peter Kamenicky, MD, PhD Inserm (Member of Commission Scientifique Spécialisée CSS3); Pfizer (Speaker); Amolyt Pharma (Investigator and Speaker); Ascendis Pharma (Advisory Board); and Calcilytix (Investigator).

Srividya Kidambi, MD TOPS Inc (Medical Editor and Director).

Katja Kiseljak-Vassiliades, DO HRA Pharma (Advisory Board).

Raghavendra Mirmira, PhD, MD Journal of Clinical Endocrinology and Metabolism (Editor); Veralox Therapeutics (Advisory Board); Veralox Therapeutics, HiberCell, Inc (Investigator-Initiated Award).

Connie Baum Newman, MD Food and Drug Association (FDA) for Endocrinologic and Metabolic Diseases (Advisory Committee and Consultant); Federation of Medical Women of Canada (Honorarium).

Theodora Pappa, MD, PhD Endocrine Fellows Foundation (Board of Directors), Frontiers (Editorial Board Member), Clinical Thyroidology (Associate Editor), and Eisai (Consultant).

Elizabeth N. Pearce, MD, MSc Iodine Global Network (Management Council); Journal of Clinical Endocrinology and Metabolism, DynaMed-thyroid (Editor); National Dairy Council, Merck China Symposium (Speaker); American Thyroid Association (Guidelines Task Force); World Health Organization (Advisory Panel).

Luca Persani, MD, PhD Merck, Egetis, Sandoz (Advisory Board); Merck (Speaker); Journal of Clinical Endocrinology and Metabolism, European Thyroid Association, European Thyroid Journal, Pituitary Society, Pituitary (Editor).

Laura Torchen, MD Levo therapeutics, IBSA Pharma (Investigator)

Elena Tsourdi, MD Amgen, Kyowa Kirin, UCB, Alexion, Ascendis (Clinical Studies); Amgen, UCB, Ascendis (Advisory Boards and Lectures); UCB, Takeda, Ascendis (Educational Grants)

Adina Turcu, MD, MS NIH/NIDDK/NHLBI (Grant Recipient), ESAP (Questions Writer), JCEM: Case Reports (Deputy Editor), and AstraZeneca (Advisor).

Corrine Kolka Welt, MD UpToDate.

The following AMSC members reported no relevant financial relationships:

Ana Paula Abreu Metzger, MD, PhD; Olga Astapova, MD, PhD; Laura Boucai, MD; Ana Pinheiro Machado Canton, MD, PhD; Hebatullah M. Ismail, MD; Julie Refardt, MD, PhD; and Jun Yang, MBBS, PhD.


EndoCareers \| Contact Us \| Privacy Policy \| Terms of Use	CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.	2055 L Street NW, Suite 600 \| Washington, DC 20036 202.971.3636 \| 888.363.6274